Literature DB >> 16780135

[A case of group B Streptococcus endogenous endophthalmitis in elderly man with diabetes mellitus].

Hideta Nakamura1, Shunichi Kinjyo, Hirosi Kaneshima, Jiro Fujita.   

Abstract

Endogenous endophthalmitis (EBE) is intraocular infection usually associated by bcteremia. Although, EBE is an uncommon disease, visually prognosis is very poor. Immune suppressive disease, such as diabetes or malignancy is a predisposing factor of EBE. Although, in east Asia, including Japan, gram negative organisms reported as common pathogen causing EBE, we here repot a case of group B streptococcus EBE. A 53- year old man, who has history of diabetes mellitus, was admitted to our hospital with compliant of sudden visual loss and pain at his right eye. His visual acuity was no hand perception in the right. In auscultation, there were coarse crackles at his left lung. Axial magnetic resonance imaging of eye showed exophthalmos of right eye and cellulites. Chest radiography revealed infiltration at the left middle lung field. EBE and pneumonia due to GBS were diagnosed and he was treated with intravenous cefotaxim. Despite of administration of antibiotics and vitreous surgery, deterioration of his visual activity was observed. Therefore antibiotics were changed to intravenous vancomicin and topical levofloxacin and amykacin were added also. But he finally lost his visual acuity of right eye.

Entities:  

Mesh:

Year:  2006        PMID: 16780135     DOI: 10.11150/kansenshogakuzasshi1970.80.267

Source DB:  PubMed          Journal:  Kansenshogaku Zasshi        ISSN: 0387-5911


  2 in total

1.  Crystalline lens dislocation secondary to bacterial endogenous endophthalmitis.

Authors:  Amit Sangave; Rahul Komati; Allison Weinmann; Linoj Samuel; Uday Desai
Journal:  Am J Ophthalmol Case Rep       Date:  2017-07-08

Review 2.  Endogenous endophthalmitis caused by group B streptococcus; case reports and review of 35 reported cases.

Authors:  Masaaki Yoshida; Shunji Yokokura; Takashi Nishida; Kiyofumi Mochizuki; Takashi Suzuki; Kazuichi Maruyama; Takaaki Otomo; Koji M Nishiguchi; Hiroshi Kunikata; Toru Nakazawa
Journal:  BMC Ophthalmol       Date:  2020-03-31       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.